– Enrollment Stopped Early for Efficacy – EXTON, Pa., May 17, 2022 — Idera Pharmaceuticals, Inc. (“Idera,” “we,” and “our”) (NASDAQ: IDRA) today shared positive interim results from Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands, … Continue reading Idera Pharmaceuticals (NASDAQ: IDRA)Shares Positive Results from Investigator-Sponsored Trial in Melanoma Patients at Amsterdam UMC